CD274 and ovarian cancer: Further studies show that miR-424 regulates the PD-L1/PD-1 and CD80/CTLA-4 pathways in drug-resistant ovarian cancer [65], and restoration of its expression reverses the chemoresistance that accompanies PD-L1 immune checkpoint blockage [66].